Skip to main content
. 2015 Jul 10;26(1):53–59. doi: 10.1055/s-0035-1556054

Table 3. Characteristics of nonrespondersa .

Variables N (%) 95% CI
Age (y), median, range 33 (22–59)
Gender
 Female 17 (45.9) 29.7–62.1
 Male 20 (54.1) 37.9–70.3
BMI (kg/m2), median, range 24 (19–32)
Fracture
 Foot 21 (56.8) 40.5–73.0
 Ankle 15 (40.5) 24.3–56.8
 Ankle + foot 1 (2.7) 0.0–8.1
 Ipsilateral 34 (91.1) 81.1–100.0
 Bilateral 3 (8.1) 0.0–18.9
Immobilization
 Full cast 0 0
 Backslab 9 (24.3) 10.8–37.8
 CAMboot 25 (67.6) 51.4–81.1
 Pressure bandage 1 (2.7) 0.0–8.1
 None 2 (5.4) 0.0–13.5
Weight-bearing status
 NWB 20 (54.1) 37.8–70.3
 PWB 5 (13.5) 2.7–24.3
 WBAT 12 (32.4) 18.9–48.6
DVT symptoms
 None 33 (89.2) 78.4–97.3
 Calf pain 2 (5.4) 0.0–13.5
 Edema 1 (2.7) 0.0–8.1
 Combination 1 (2.7) 0.0–8.1
Time to fracture clinic (d), median, range 17 (7–70)
Smoking status
 Nonsmoker 17 (45.9) 29.7–62.2
 Exsmoker 12 (32.4) 18.9–48.6
 Current 8 (21.6) 8.1–35.1
History of current OCP useb 4/17 (23.5) 5.9–43.8
History of current HRT useb 1/17 (5.9) 0.0–20.0
Family history of VTE 1 (2.7) 0.0–8.1

Abbreviations: BMI, body mass index; CAMboot, controlled ankle movement boot; CI, confidence interval; DVT, deep vein thrombosis; HRT, hormone replacement therapy; NWB, nonweight bearing; OCP, oral contraceptive pill; PWB, partial weight bearing; VTE, venous thromboembolism; WBAT, weight bearing as tolerated.

a

n = 37.

b

This data are for female patients (n = 17).

Note: No patients had history of active cancer or clotting/bleeding disorders.